4//SEC Filing
Valle William 4
Accession 0001415889-25-002541
CIK 0001826667other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:00 PM ET
Size
8.0 KB
Accession
0001415889-25-002541
Insider Transaction Report
Form 4
Valle William
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-29+6,250→ 6,250 totalExercise: $4.89Exp: 2035-01-28→ Common Stock (6,250 underlying) - Award
Director Stock Option (right to buy)
2025-01-29+35,000→ 35,000 totalExercise: $4.89Exp: 2035-01-28→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]The shares subject to the option shall fully vest on the one-year anniversary of the grant date of January 29, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0002018493
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:00 PM ET
- Size
- 8.0 KB